The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Open accessAbstract
PURPOSE: Antimicrobial peptides (AMPs) are an essential part of innate immunity that evolved in most living organisms over 2.6 billion years to combat microbial challenge. These small cationic peptides are multifunctional as effectors of innate immunity on skin and mucosal surfaces and have demonstrated direct antimicrobial activity against various bacteria, viruses, fungi, and parasites. This review summarizes their progress to date as commercial antimicrobial drugs for topical and systemic indications. METHODS: Literature review. RESULTS: Despite numerous clinical trials, no modified AMP has obtained Food & Drug Administration approval yet for any topical or systemic medical indications. CONCLUSIONS: While AMPs are recognized as essential components of natural host innate immunity against microbial challenge, their usefulness as a new class of antimicrobial drugs still remains to be proven.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Contribution of Human α-Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor
Zhang, L., Yu, W., He, T., Yu, J., Caffrey, R. E., Dalmasso, E. A., Fu, S., Pham, T., Mei, J., Ho, J. J., et al. (2002) · Science · doi:10.1126/science.1076185 · Cited by 468
RetractedAntimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
Mode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
Cationic peptides: a new source of antibiotics
Hancock, R. E. W., & Lehrer, R. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01156-6 · Cited by 1,336
Beutler, B. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.005 · Cited by 1,276
Antiviral drugs in current clinical use
De Clercq, E. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.02.009 · Cited by 947
Mammalian defensins in immunity: more than just microbicidal
Yang, D., Biragyn, A., Kwak, L. W., & Oppenheim, J. J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02246-9 · Cited by 696
Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J., & Oppenheim, J. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104603 · Cited by 572
Direct inactivation of viruses by human granulocyte defensins
Daher, K. A., Selsted, M. E., & Lehrer, R. I. (1986) · Journal of Virology · doi:10.1128/jvi.60.3.1068-1074.1986 · Cited by 533
Antimicrobial peptides in animals and their role in host defences
Brogden, K. A., Ackermann, M., McCray, P. B., & Tack, B. F. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00180-8 · Cited by 458
Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication
Quiñones-Mateu, M. E., Lederman, M. M., Feng, Z., Chakraborty, B., Weber, J., Rangel, H. R., Marotta, M. L., Mirza, M., Jiang, B., Kiser, P., et al. (2003) · AIDS · doi:10.1097/00002030-200311070-00001 · Cited by 424
Levin, M., Quint, P. A., Goldstein, B., Barton, P., Bradley, J. S., Shemie, S., Yeh, T., Kim, S. S., Cafaro, D. P., Scannon, P. J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02712-4 · Cited by 411
Emerging fluoroquinolone resistance in bacterial keratitis
Goldstein, M. H., Kowalski, R. P., & Gordon, Y. J. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)00716-2 · Cited by 408
Self-citationMultidimensional signatures in antimicrobial peptides
Yount, N. Y., & Yeaman, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401567101 · Cited by 402
In Vitro Antibacterial Properties of Pexiganan, an Analog of Magainin
Ge, Y., MacDonald, D. L., Holroyd, K. J., Thornsberry, C., Wexler, H., & Zasloff, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.782 · Cited by 359
Antimicrobial Peptides: Properties and Applicability
Hof, W. V. T., Veerman, E. C. I., Helmerhorst, E. J., & Amerongen, A. V. N. (2001) · Biological Chemistry · doi:10.1515/bc.2001.072 · Cited by 354
Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics
Mather, R., Karenchak, L. M., Romanowski, E. G., et al. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01334-x · Cited by 345
Self-citationAntimicrobial Peptides: Current Status and Therapeutic Potential
Koczulla, A. R., & Bals, R. (2003) · Drugs · doi:10.2165/00003495-200363040-00005 · Cited by 306
Can innate immunity be enhanced to treat microbial infections?
Finlay, B. B., & Hancock, R. E. W. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro908 · Cited by 298
Cationic Antimicrobial Peptides: Issues for Potential Clinical Use
Bradshaw, J. P. (2003) · BioDrugs · doi:10.2165/00063030-200317040-00002 · Cited by 293
Kowalski, R. P., Dhaliwal, D. K., Karenchak, L. M., Romanowski, E. G., Mah, F. S., Ritterband, D. C., & Gordon, Y. J. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00294-0 · Cited by 266
Self-citationYasin, B., Wang, W., Pang, M., Cheshenko, N., Hong, T., Waring, A. J., Herold, B. C., Wagar, E. A., & Lehrer, R. I. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5147-5156.2004 · Cited by 254
Gordon, Y. J., Huang, L. C., Romanowski, E. G., Yates, K. A., Proske, R. J., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590934111 · Cited by 252
Self-citationMidorikawa, K., Ouhara, K., Komatsuzawa, H., Kawai, T., Yamada, S., Fujiwara, T., Yamazaki, K., Sayama, K., Taubman, M. A., Kurihara, H., et al. (2003) · Infection and Immunity · doi:10.1128/iai.71.7.3730-3739.2003 · Cited by 234
Histatins: Antimicrobial peptides with therapeutic potential
Kavanagh, K., & Dowd, S. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022971 · Cited by 223
Defensins are mitogenic for epithelial cells and fibroblasts
Murphy, C. J., Foster, B. A., Mannis, M. J., Selsted, M. E., & Reid, T. W. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041550223 · Cited by 195
Activity of α- and θ-Defensins against Primary Isolates of HIV-1
Wang, W., Owen, S. M., Rudolph, D. L., Cole, A. M., Hong, T., Waring, A. J., Lal, R. B., & Lehrer, R. I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.515 · Cited by 194
McDermott, A. M., Redfern, R. L., Zhang, B., Pei, Y., Huang, L., & Proske, R. J. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0787 · Cited by 187
Self-citationAntibiotic Resistance: What Is the Impact of Agricultural Uses of Antibiotics on Children’s Health?
Shea, K. M. (2003) · PEDIATRICS · doi:10.1542/peds.112.s1.253 · Cited by 177
Antimicrobial defensin peptides of the human ocular surface
Haynes, R. J., Tighe, P. J., & Dua, H. S. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.6.737 · Cited by 175
Panyutich, A. V., Shi, J. N., Boutz, P. L., Zhao, C., & Ganz, T. (1997) · Infection and Immunity · doi:10.1128/iai.65.3.978-985.1997 · Cited by 153
Antimicrobial therapy to prevent or treat oral mucositis
Donnelly, J. P., Bellm, L. A., Epstein, J. B., Sonis, S. T., & Symonds, R. P. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00668-6 · Cited by 150
Trotti, A., Garden, A. S., Warde, P. R., Symonds, P. R., Langer, C. J., Redman, R. L., Pajak, T. F., Fleming, T. R., Henke, M., Bourhis, J., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)01627-4 · Cited by 148
Sader, H. S., Fedler, K. A., Rennie, R. P., Stevens, S., & Jones, R. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3112-3118.2004 · Cited by 144
Sinha, S., Cheshenko, N., Lehrer, R. I., & Herold, B. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.494-500.2003 · Cited by 118
Lamb, H. M., & Wiseman, L. R. (1998) · Drugs · doi:10.2165/00003495-199856060-00011 · Cited by 108
Endogenous production of antimicrobial peptides in innate immunity and human disease
Gallo, R. L., & Nizet, V. (2003) · Current Allergy and Asthma Reports · doi:10.1007/s11882-003-0074-x · Cited by 89
Coronado, V. G., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, T. N. N. I. S. (. (1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30140945 · Cited by 86
Giles, F. J., Rodríguez, R., Weisdorf, D. J., Wingard, J. R., Martin, P. J., Fleming, T. R., Goldberg, S. L., Anaissie, E. J., Bolwell, B. J., Chao, N. J. A., et al. (2003) · Leukemia Research · doi:10.1016/j.leukres.2003.10.021 · Cited by 83
The Innate Immune Response to Infection
Kaufmann, S. H. E., Medzhitov, R. M., & Gordon, S. (2004) · ASM Press eBooks · doi:10.1128/9781555817671 · Cited by 76
Expression of Human β-Defensins in Conjunctival Epithelium: Relevance to Dry Eye Disease
Narayanan, S., Miller, W. L., & McDermott, A. M. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1301 · Cited by 75
Self-citationTopical Antibacterial Treatments for Acne Vulgaris: Comparative Review and Guide to Selection
Tan, H.-H. (2004) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200405020-00002 · Cited by 61
Cationic antimicrobial peptides: update of clinical development
Andrès, E., & Dimarcq, J. L. (2004) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01278.x · Cited by 57
The big and small of drug discovery
Moore, A. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor748 · Cited by 54
Treatment of Infected Wounds with the Antimicrobial Peptide D2A21
Chalekson, C. P., Neumeister, M. W., & Jaynes, J. M. (2003) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000047047.79701.6d · Cited by 45
Improvement in Burn Wound Infection and Survival with Antimicrobial Peptide D2A21 (Demegel)
Chalekson, C. P., Neumeister, M. W., & Jaynes, J. M. (2002) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200204010-00020 · Cited by 44
Mannis, M. J. (2002) · PubMed Central · Cited by 42
Antibiotic Resistance: The Pandemic
Verhoef, J. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0059-9_26 · Cited by 24
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
TFOS DEWS II pathophysiology report
Bron, A. J., de Paiva, C. S., Chauhan, S. K., Bonini, S., Gabison, E. E., Jain, S., Knop, E., Markoulli, M., Ogawa, Y., Perez, V., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.011 · Cited by 1,815
Pseudomonas aeruginosa Biofilms
Thi, M. T. T., Wibowo, D., & Rehm, B. H. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228671 · Cited by 911
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Metadata
- Authors
- Gordon, Y. J., Romanowski, E. G., & McDermott, A. M.
- Venue
- Current Eye Research
- Publisher
- Informa UK Limited
- Published
- 2005-01
- Volume
- 30
- Issue
- 7
- Pages
- 505-515
- ISSN
- 0271-3683 (ISSN-L)
- 1460-2202
- OpenAlex
- W1969711244
- Cited by
- 697
- References
- 51
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.